
Amit A Patel MD
Hematologic Oncology
President, Medical/Dental Staff at RWJ Barnabas Health - Jersey City Medical Center Physician Partner, Astera Cancer Care/OneOncology
Join to View Full Profile
1 Exchange PlaceJersey City, NJ 07302
Phone+1 732-390-7750
Fax+1 201-201-7234
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amit Patel is an oncologist in Jersey City, NJ and is affiliated with multiple hospitals in the area, including Jersey City Medical Center, CarePoint Health Bayonne Medical Center, and CarePoint Health Christ Hospital. He received his medical degree from St. George's University School of Medicine and has been in practice 12 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2005 - 2008
St. George's University School of MedicineClass of 2005
Certifications & Licensure
NJ State Medical License 2012 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013-2014
Publications & Presentations
PubMed
- Danazol and cost-savings in immune thrombocytopenia and in immune thrombotic thrombocytopenic purpura.Mala Varma, Ilan Shapira, Mark Friedman, Ibrahim Nakhoul, Vamsee Torri
Blood Coagulation & Fibrinolysis. 2025-12-01 - 4 citationsIn Reference to "Partial Epiglottoplasty for Pharyngeal Dysphagia due to Cervical Spine Pathology".Amit A. Patel, Christopher G. Tang, Andrew Blitzer
Otolaryngology--Head and Neck Surgery. 2016-04-01 - 24 citationsSubglottic Squamous Cell Carcinoma: A Population-Based Study of 889 CasesEmily Marchiano, Dhruv M. Patel, Tapan D. Patel, Amit A. Patel, Yuhan E. Xue
Otolaryngology--Head and Neck Surgery. 2016-02-01
Press Mentions
Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels That Feed CancerNovember 7th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









